In hepatocellular carcinoma, A-to-I editing of the antizyme inhibitor 1 (AZIN1) increases and neutralizes a key inhibitor of the polyamine synthesis pathway, thereby promoting proliferation in vitro and increasing tumor initiation and volume in a mouse xenograft model (Chen et al., 2013). Here, AZIN1 is linked to neoplasm.